about
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortiumAssociations of Body Mass Index With Incident Fractures and Hip Structural Parameters in a Large Canadian Cohort.Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factorsSex hormones and the risk of incident prostate cancerPrevalence of HPV infection among men: A systematic review of the literature.The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men studyBMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS).Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United StatesAssociations of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D With Bone Mineral Density, Bone Mineral Density Change, and Incident Nonvertebral Fracture.Mortality risk in older men associated with changes in weight, lean mass, and fat mass.The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.Distribution of bone density in the proximal femur and its association with hip fracture risk in older men: the osteoporotic fractures in men (MrOS) study.The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study.The Association Between BMI and QCT-Derived Proximal Hip Structure and Strength in Older Men: A Cross-Sectional StudySex hormones, sex hormone binding globulin, and vertebral fractures in older men.Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic AssociationsTime to Osteoporosis and Major Fracture in Older Men: The MrOS StudyAssociations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men.Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material StrengthRare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density.Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners.Multimorbidity and Functional Limitations Among Adults 65 or Older, NHANES 2005-2012.Risk factors for anogenital human papillomavirus infection in men.Sex and the single nucleotide polymorphism: exploring the genetic causes of skeletal sex differences.Vitamin D and DBP: the free hormone hypothesis revisited.Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics.Cervical cancer incidence in the United States in the US-Mexico border region, 1998-2003.HPV 6/11, 16, 18 seroprevalence in men in two US cities.Role of Assay Type in Determining Free 25-Hydroxyvitamin D Levels in Diverse Populations.Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men.Breast cancer among Hispanic and non-Hispanic White women in Arizona.High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men.Test-retest reliability and predictors of unreliable reporting for a sexual behavior questionnaire for U.S. men.Reliability of sample collection and laboratory testing for HPV detection in men.Estimated Lean Mass and Fat Mass Differentially Affect Femoral Bone Density and Strength Index but Are Not FRAX Independent Risk Factors for FracturePositive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trialHuman papillomavirus prevalence and type distribution in male anogenital sites and semenDesign and validation of a multiplex specific primer-directed polymerase chain reaction assay for killer-cell immunoglobulin-like receptor genetic profilingGenetic Burden Contributing to Extremely Low or High Bone Mineral Density in a Senior Male Population From the Osteoporotic Fractures in Men Study (MrOS)
P50
Q30579240-57C2CF96-DC97-4FC6-AF89-4806F95A0663Q33570559-C9D4C60E-3CAD-4188-B8B4-09378E994E99Q33633353-58F86ABE-1B35-43B3-A439-9FD30F9CDC27Q34274282-1DE62235-E97F-4CF2-9D54-9DE6816BC04FQ34567930-1B6CDFEA-94D8-49FF-ABED-5D44ED5C5413Q34705454-0621F861-82D6-4D25-99C5-F72F3B1542B6Q35229885-0ED479EF-2084-4724-AA1B-D280DA065869Q35842294-B15C550E-8613-4B53-A6FE-87620760BA77Q35864004-245636A3-0B6A-4282-9976-9BAD2D477D8CQ36111983-9F7B16B3-C595-4DF3-BC45-404D72B4B1EBQ36318963-34E9AF0D-AF2A-45DB-8103-9CCF27438003Q36328468-0623C660-099A-4E5E-B949-5AF74AA1535FQ36328511-8690CB03-2184-4C7F-9749-E890EB713975Q36585377-61E99094-F421-43C6-B65F-D79B50B77FEAQ36586017-8DF0E763-A58A-4E69-8322-A12E4F6A4A61Q36911469-1039CFA5-D778-4459-8A52-236C000BAF34Q36923905-7C179D7C-B245-4011-ACAE-7F6688D96AE5Q36993959-E8212455-DF89-4B2E-A185-78BCF2448478Q37220028-C1029806-8F1D-4BC8-95DF-DE4FCA0D05E4Q37260845-48915DF0-0309-476F-B2E9-EA3B2DF4FA99Q37348083-21C40787-77A0-4FE0-A267-9B1CC32D1D2EQ37392312-FA654C77-1F9A-40E6-8B89-EEC7DBBA13F2Q37425035-8FE6E640-C9C7-4E53-8211-330D83F3D6F9Q37605194-8813D4C5-FA47-49BA-B616-AF3B68A3CF8BQ37685960-8DB93686-7233-49F6-9645-97CA5E9E40ECQ38743204-441D5E23-8A5D-4BA2-A9BD-F4085080AF04Q39861129-D575A061-5D97-47B6-86E9-A1253771FDC2Q39903046-714D3D8C-B44C-435A-A45D-1EFEB07F083EQ42781846-40B88B33-6943-4636-A8A0-C300F92C3893Q44028516-479BF977-2DC9-4B5F-B4F5-B65A34F595F8Q44846081-05DA4DD0-603C-40AA-8088-885E44B12D2AQ48107682-6376AB7F-73FE-49AA-9BE0-5EAA4E27C967Q51618009-20FC1BD7-944D-4E4B-8649-28A29A8359AEQ54546272-37A2272A-949C-46CB-BBAB-903F7A5BA108Q57711219-B6F9195C-F661-4680-8724-AB8B32A04BD4Q58784194-D50A6ED2-FF40-4EEA-AE84-7F0C757A1F29Q80428065-417CEF8D-EDCA-43FF-BBA0-3AF8D9FCCC78Q83150368-E3265D97-8307-4497-BC51-F53188C9EF24Q90250614-AAF5F13A-F5F2-4BC4-B73A-30ABCB8831EB
P50
description
investigador
@es
researcher
@en
name
Carrie M Nielson
@en
Carrie M Nielson
@nl
type
label
Carrie M Nielson
@en
Carrie M Nielson
@nl
prefLabel
Carrie M Nielson
@en
Carrie M Nielson
@nl
P31
P496
0000-0002-2619-7839